SE9604610D0 - Medical composition - Google Patents

Medical composition

Info

Publication number
SE9604610D0
SE9604610D0 SE9604610A SE9604610A SE9604610D0 SE 9604610 D0 SE9604610 D0 SE 9604610D0 SE 9604610 A SE9604610 A SE 9604610A SE 9604610 A SE9604610 A SE 9604610A SE 9604610 D0 SE9604610 D0 SE 9604610D0
Authority
SE
Sweden
Prior art keywords
derivatives
cationic
edta
taurine
anionic
Prior art date
Application number
SE9604610A
Other languages
English (en)
Swedish (sv)
Inventor
Benny Johansson
Bo Niklasson
Original Assignee
Noviscens Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noviscens Ab filed Critical Noviscens Ab
Priority to SE9604610A priority Critical patent/SE9604610D0/xx
Publication of SE9604610D0 publication Critical patent/SE9604610D0/xx
Priority to CA002275321A priority patent/CA2275321C/en
Priority to NZ336313A priority patent/NZ336313A/en
Priority to CN97181506A priority patent/CN1245431A/zh
Priority to PCT/SE1997/002126 priority patent/WO1998026788A1/en
Priority to AU55027/98A priority patent/AU720008B2/en
Priority to EP97951368A priority patent/EP0957927B1/de
Priority to RO99-00675A priority patent/RO120122B1/ro
Priority to DE69732495T priority patent/DE69732495T2/de
Priority to HU0000557A priority patent/HUP0000557A3/hu
Priority to AT97951368T priority patent/ATE288760T1/de
Priority to CZ19992135A priority patent/CZ295459B6/cs
Priority to KR1019997005424A priority patent/KR20000069521A/ko
Priority to PL333915A priority patent/PL191316B1/pl
Priority to JP52761998A priority patent/JP4703792B2/ja
Priority to ES97951368T priority patent/ES2236837T3/es
Priority to NO19992841A priority patent/NO321048B1/no
Priority to US09/334,264 priority patent/US6562802B2/en
Priority to HK00101714A priority patent/HK1022644A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
SE9604610A 1996-12-16 1996-12-16 Medical composition SE9604610D0 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE9604610A SE9604610D0 (sv) 1996-12-16 1996-12-16 Medical composition
ES97951368T ES2236837T3 (es) 1996-12-16 1997-12-16 Composicion medica y su uso para la fabricacion de una formulacion barrera topica, una formulacion absorbente de la radiacion uv, o una formulacion antiviral, antifungica o antiinflamatoria.
DE69732495T DE69732495T2 (de) 1996-12-16 1997-12-16 Medizinische zusammensetzung und dessen verwendung zur herstellung einer topischen barriere-formulierung, einer uv-strahlung absorbierenden formulierung oder einer antiviralen, fungiziden oder entzuendungshemmenden formulierung
AT97951368T ATE288760T1 (de) 1996-12-16 1997-12-16 Medizinische zusammensetzung und dessen verwendung zur herstellung einer topischen barriere-formulierung, einer uv-strahlung absorbierenden formulierung oder einer antiviralen, fungiziden oder entzuendungshemmenden formulierung
CN97181506A CN1245431A (zh) 1996-12-16 1997-12-16 药物组合物及其在制备局部防护制剂、紫外辐射吸收剂或抗病毒、抗真菌或抗炎制剂中的应用
PCT/SE1997/002126 WO1998026788A1 (en) 1996-12-16 1997-12-16 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
AU55027/98A AU720008B2 (en) 1996-12-16 1997-12-16 Medical composition and use thereof for the manufacture of topical barrier formulation, a UV-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
EP97951368A EP0957927B1 (de) 1996-12-16 1997-12-16 Medizinische zusammensetzung und dessen verwendung zur herstellung einer topischen barriere-formulierung, einer uv-strahlung absorbierenden formulierung oder einer antiviralen, fungiziden oder entzuendungshemmenden formulierung
RO99-00675A RO120122B1 (ro) 1996-12-16 1997-12-16 Compoziţie medicală şi utilizare, ca medicament, în formulare protectivă locală, formulare pentru absorbţia radiaţiilor uv, sau a unei formulări antivirale, antifungice sau antiinflamatorii
CA002275321A CA2275321C (en) 1996-12-16 1997-12-16 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
HU0000557A HUP0000557A3 (en) 1996-12-16 1997-12-16 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation,or an antiviral,antifungal,or antiinflammatory formulation
NZ336313A NZ336313A (en) 1996-12-16 1997-12-16 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, antiinflammatory formulation
CZ19992135A CZ295459B6 (cs) 1996-12-16 1997-12-16 Farmaceutický přípravek pro použití jako medikament v místním bariérovém prostředku, prostředku absorbujícím UV záření, a antivirovém, antifungálním a protizánětlivém prostředku
KR1019997005424A KR20000069521A (ko) 1996-12-16 1997-12-16 의료용 조성물, 및 국소용 장벽 제형, 자외선 흡수 제형, 또는 항바이러스성, 항진균성 또는 항염증성 제형의 제조를 위한 이의 용도
PL333915A PL191316B1 (pl) 1996-12-16 1997-12-16 Kompozycja do zastosowania jako lek w miejscowym preparacie barierowym, preparacie pochłaniającym promieniowanie UV i preparacie przeciwwirusowym, przeciwgrzybicznym lub przeciwzapalnym i jej zastosowanie do wytwarzania preparatu
JP52761998A JP4703792B2 (ja) 1996-12-16 1997-12-16 医用組成物、ならびに局所保護調合物、ｕｖ−放射吸収調合物、または抗ウイルス、抗真菌もしくは抗炎症調合物の製造のためのその使用
NO19992841A NO321048B1 (no) 1996-12-16 1999-06-11 Medisinsk preparat og anvendelse derav til fremstilling av et topisk barrieremateriale, et UV-straleabsorberende materiale, eller et middel mot virus, sopp eller betennelser
US09/334,264 US6562802B2 (en) 1996-12-16 1999-06-16 Medical composition and uses thereof
HK00101714A HK1022644A1 (en) 1996-12-16 2000-03-21 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604610A SE9604610D0 (sv) 1996-12-16 1996-12-16 Medical composition

Publications (1)

Publication Number Publication Date
SE9604610D0 true SE9604610D0 (sv) 1996-12-16

Family

ID=20404983

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9604610A SE9604610D0 (sv) 1996-12-16 1996-12-16 Medical composition

Country Status (19)

Country Link
US (1) US6562802B2 (de)
EP (1) EP0957927B1 (de)
JP (1) JP4703792B2 (de)
KR (1) KR20000069521A (de)
CN (1) CN1245431A (de)
AT (1) ATE288760T1 (de)
AU (1) AU720008B2 (de)
CA (1) CA2275321C (de)
CZ (1) CZ295459B6 (de)
DE (1) DE69732495T2 (de)
ES (1) ES2236837T3 (de)
HK (1) HK1022644A1 (de)
HU (1) HUP0000557A3 (de)
NO (1) NO321048B1 (de)
NZ (1) NZ336313A (de)
PL (1) PL191316B1 (de)
RO (1) RO120122B1 (de)
SE (1) SE9604610D0 (de)
WO (1) WO1998026788A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2710300A (en) * 1998-12-24 2000-07-31 Four Star Partners Compositions and methods of using the same
CA2393732C (en) * 1999-12-17 2005-12-20 The Procter & Gamble Company Compositions for efficient release of active ingredients
CA2394901A1 (en) * 1999-12-23 2001-06-28 Ivrea, Inc. Chitosan biopolymer for the topical delivery of active agents
JP4771502B2 (ja) * 2000-06-13 2011-09-14 住化エンビロサイエンス株式会社 抗アレルゲン組成物及びアレルゲン不活化方法
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
GB0019283D0 (en) * 2000-08-04 2000-09-27 Novartis Ag Organic compounds
WO2002019981A2 (en) * 2000-09-11 2002-03-14 Johnson & Johnson Gmbh Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
US20040052826A1 (en) * 2000-09-11 2004-03-18 Elena Fernandez-Kleinlein Cosmetic and pharmaceutical compositions and their use
GB0024489D0 (en) * 2000-10-06 2000-11-22 Reckitt Benckiser Uk Ltd Improvements in or relating to organic compositions
ATE316786T1 (de) * 2000-11-22 2006-02-15 Rxkinetix Inc Behandlung von mukositis
KR100423666B1 (ko) * 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
US7998699B2 (en) 2002-08-15 2011-08-16 University Of South Florida Early detection of pathogens in blood
CN100453121C (zh) * 2002-11-12 2009-01-21 吴奕光 一种医用敷料及其生产方法
EP1438954A1 (de) * 2003-01-18 2004-07-21 Beiersdorf AG Erhöhung der Thermostabilität und Verbesserung der Fliesseigenschaften von chitosanhaltigen Formulierungen
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
PL1654387T3 (pl) * 2003-08-15 2009-10-30 Univ South Florida Materiały i sposoby do wychwytywania patogenów i usuwania kwasu aurynotrikarboksylowego z próbki
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
US20060127342A1 (en) * 2004-12-09 2006-06-15 Georgia Levis Taurine-based compositions, therapeutic methods, and assays
US20100239655A1 (en) * 2004-12-09 2010-09-23 Georgia Levis Taurine-based compositions and therapeutic methods
US7691830B2 (en) * 2005-02-17 2010-04-06 Clive Elson Method and composition for treatment of a mucosal tissue disorder
US7311050B2 (en) * 2005-04-19 2007-12-25 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
DK1965787T3 (da) * 2005-11-30 2013-06-03 Endo Pharmaceuticals Inc Behandling af xerostomi med en svovlindeholdende antioxidant
EP2040716B1 (de) * 2006-04-04 2010-07-28 Marinomed Biotechnologie GmbH Cellulosesulfat zur behandlung von rhinovirus-infektionen
DK2026880T3 (en) * 2006-05-05 2018-10-01 Blaa Lonid Hf PHARMACEUTICAL AND COSMETIC APPLICATION OF SILICA
US7964002B2 (en) 2006-06-14 2011-06-21 Chemtura Corporation Antioxidant additive for biodiesel fuels
EP1958639A1 (de) * 2007-02-14 2008-08-20 Polichem S.A. Verwendung von Chitosanen zur Behandlung von Entzündungserkrankungen der Nägel
US10201490B2 (en) 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
EP1958613A1 (de) * 2007-02-15 2008-08-20 Polichem S.A. Dermale filmbildende flüssige Formulierungen zur Wirkstofffreisetzung auf der Haut
US20100055132A1 (en) 2007-04-04 2010-03-04 Thomas Dag Horn Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
US20090004288A1 (en) * 2007-06-29 2009-01-01 Collins Gary L Stabilized ophthalmic solutions
US8131278B2 (en) * 2008-12-05 2012-03-06 Nokia Corporation Method, apparatus, and computer program product for application-based communications
US20120010167A1 (en) * 2009-03-19 2012-01-12 Gregory Kenton W Countermeasure methods and devices
WO2010109421A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroids cream comprising chitosan and a process to make it
US20120115828A1 (en) * 2009-04-20 2012-05-10 Apex Laboratories Private Limited Medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
US20120040927A1 (en) * 2009-04-20 2012-02-16 Apex Laboratories Private Limited Medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it.
WO2011041680A2 (en) * 2009-10-02 2011-04-07 The Brigham And Women's Hospital, Inc. Compositions and methods of prophylaxis for contact dermatitis
US20110225809A1 (en) * 2010-03-17 2011-09-22 Alan Francis Daher Apparatus for removably attaching an item to a surface
CN103479400A (zh) * 2012-06-11 2014-01-01 浙江我武生物科技股份有限公司 一种含有漆酚的皮炎诊断贴剂及其制备方法
FR2993466B1 (fr) * 2012-07-18 2014-08-15 Prevor Internat Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau
US20150209275A1 (en) * 2012-09-11 2015-07-30 University Of The Witwatersrand, Johannesburg Fast Dissolving Ocular Insert
CN103951763B (zh) * 2014-04-22 2016-06-22 大连民族学院 O-烷基氨基甲酸酯壳聚糖、转基因复合物微粒及其制备方法
WO2016019981A1 (en) * 2014-08-05 2016-02-11 Amantin Experts Protective skin compositions
CA2976268C (en) 2015-02-26 2021-07-06 Squarex, Llc Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
PL3124016T3 (pl) * 2015-07-31 2020-04-30 Warszawski Uniwersytet Medyczny Przeciwłuszczycowa kompozycja emulsyjna zawierająca cefazolinę
JP2018184362A (ja) * 2017-04-25 2018-11-22 株式会社Ｒ−ｇｏｏｄ 殺菌性組成物
CN107973866B (zh) * 2017-12-15 2020-08-28 武汉工程大学 具有高的sod酶活性的四氮大环锰配合物修饰壳聚糖复合材料及其制备方法
CN108892743A (zh) * 2018-05-28 2018-11-27 南京工业大学 用于光动力抗菌的纳米光敏剂，其制备方法及应用
CN115177738B (zh) * 2022-05-07 2024-07-30 中国人民解放军陆军军医大学第一附属医院 一种促进核素排泄的乙二醇壳聚糖dtpa及其制备方法
WO2024013711A1 (en) 2022-07-15 2024-01-18 Universidade De Coimbra Topical composition and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1027501B (it) * 1968-12-06 1978-12-20 Muzzarelli Weckx M G F Chitina chitosano e derivati usati come supporti cromatografici e come adsorbenti per la raccolta di ioni dalle soluzuoni acquose e organiche dall acqua potabile e marina
US4031025A (en) * 1971-05-10 1977-06-21 Societe Anonyme Dite: L'oreal Chitosan derivative, sequestering agents for heavy metals
US3879376A (en) * 1971-05-10 1975-04-22 Oreal Chitosan derivative, method of making the same and cosmetic composition containing the same
US4382864A (en) * 1980-08-08 1983-05-10 Kurita Water Industries Ltd. Process for dewatering sludges
DE3245784A1 (de) * 1982-12-10 1984-06-14 Wella Ag, 6100 Darmstadt Kosmetisches mittel auf der basis von quaternaeren chitosanderivaten, neue quaternaere chitosanderivate sowie verfahren zu ihrer herstellung
US5000945A (en) * 1986-04-22 1991-03-19 Ajinomoto Co., Inc. Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US4929722A (en) * 1986-06-06 1990-05-29 Union Carbide Chemicals And Plastics Company Inc. Acid decrystallization of aminopolysaccharides and derivatives thereof
JPH0696489B2 (ja) * 1987-05-11 1994-11-30 株式会社資生堂 皮膚および毛髪用組成物
US5744166A (en) * 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
US5140043A (en) * 1989-04-17 1992-08-18 Duke University Stable ascorbic acid compositions
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
AU9115791A (en) * 1990-11-30 1992-06-25 Baker Cummins Dermatologicals, Inc. Skin protective compositions and method of inhibiting skin irritation
US5348799A (en) * 1991-09-03 1994-09-20 Minnesota Mining And Manufacturing Company Antistatic coatings comprising chitosan acid salt and metal oxide particles
JPH07196468A (ja) * 1993-12-30 1995-08-01 Sansho Seiyaku Co Ltd 化粧料
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
SE9403138L (sv) 1994-09-20 1996-03-21 Asea Brown Boveri Manöverdon för brytare
US5698476A (en) * 1995-03-01 1997-12-16 The Clorox Company Laundry article for preventing dye carry-over and indicator therefor
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
US5646221A (en) * 1995-03-31 1997-07-08 Kowa Co., Ltd. Adhesive base material
TW427912B (en) * 1996-12-20 2001-04-01 Kao Corp Detergent composition
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations

Also Published As

Publication number Publication date
US20020128310A1 (en) 2002-09-12
KR20000069521A (ko) 2000-11-25
CA2275321A1 (en) 1998-06-25
PL191316B1 (pl) 2006-04-28
NO992841L (no) 1999-08-16
WO1998026788A1 (en) 1998-06-25
ES2236837T3 (es) 2005-07-16
AU5502798A (en) 1998-07-15
CA2275321C (en) 2009-02-03
JP2001506649A (ja) 2001-05-22
ATE288760T1 (de) 2005-02-15
EP0957927B1 (de) 2005-02-09
CN1245431A (zh) 2000-02-23
HUP0000557A3 (en) 2001-11-28
DE69732495T2 (de) 2006-01-05
HK1022644A1 (en) 2000-08-18
AU720008B2 (en) 2000-05-18
CZ213599A3 (cs) 1999-11-17
RO120122B1 (ro) 2005-09-30
CZ295459B6 (cs) 2005-08-17
JP4703792B2 (ja) 2011-06-15
NO321048B1 (no) 2006-03-06
NO992841D0 (no) 1999-06-11
HUP0000557A2 (hu) 2000-06-28
DE69732495D1 (de) 2005-03-17
EP0957927A1 (de) 1999-11-24
US6562802B2 (en) 2003-05-13
PL333915A1 (en) 2000-01-31
NZ336313A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
SE9604610D0 (sv) Medical composition
CA2023919A1 (en) Light-stabilised ink compositions
NZ335116A (en) Hair composition comprising starch, polyacrylic acid, solvent and water
ES2092046T3 (es) Composicion protectora del sol.
HK1013008A1 (en) Topical personal care composition containing polysiloxane-grafted adhesive polymer and drying aid
ES2160722T3 (es) Composiciones conservadas de farmacos oftalmicos que contienen compuestos polimeros de amonio cuaternario.
BR9808181A (pt) Uso de um conservante de madeira e envoltório para a proteção suplementar de madeira
ATE233302T1 (de) Härtbare beschichtungszusammensetzungen enthaltend carbamat-zusätze
IS2935A7 (is) Efnasambönd með sérstökum storknunareiginleikum.
TR200102941T2 (tr) Farmakolojik olarak aktif bileşiklerin hücre içi taşınması için katyonik lipidler
EP0158412A3 (de) Lichtschutzmittelzusammensetzungen
AU655229B2 (en) Cationic compositions for skin
BR9907314A (pt) Utilização de um éster de celulose
BR9909087A (pt) Formulações para proteção de conjugados peg-alfa interferon
ES2078520T3 (es) Tintas de imprimir acuosas que tienen propiedades mejoradas de congelacion-descongelacion.
CA2153543A1 (fr) Composition cosmetique et/ou dermatologique gelifiee, riche en solvant et contenant des particules creuses, ses applications
ATE218156T1 (de) Verbundwerkstoff
ATE23558T1 (de) Fluessige gewebeweichmacher-zusammensetzung.
ATE416790T1 (de) Wasserlösliche trockene zusammensetzungen
CA2184163A1 (en) Compound for use in the production of rapidly hardening silicone materials which can cross-link aminosilanes
WO1999024042A3 (en) Stable antiandrogenic gel composition
EP0248366A3 (en) Smoothing agent for groutings
MX173729B (es) Composiciones curables de revestimiento que inc luyen catalizadores de sulfonimida
RU95116053A (ru) Средства для защиты древесины
CS274751B2 (en) Agent for plants' medium stress factors effects protection